No Data
Treace Medical Concepts Is Maintained at Neutral by UBS
Express News | Treace Medical Concepts Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results. Also, Truist Securities Lowered Its Price Target on the Stock From $9 to $7.5
Express News | Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $7.5
Treace Medical Concepts Analyst Ratings
Truist Financial Sticks to Their Hold Rating for Treace Medical Concepts (TMCI)
Express News | Treace Medical Concepts Inc : Stifel Raises Target Price to $7 From $6